Eurofins Scient (OTCMKTS:ERFSF) Short Interest Down 66.8% in January

Eurofins Scient (OTCMKTS:ERFSF) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totaling 86,941 shares, a drop of 66.8% from the December 31st total of 261,757 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 27,237 shares, the days-to-cover ratio is currently 3.2 days. Based on an average daily volume of 27,237 shares, the days-to-cover ratio is currently 3.2 days. Approximately 0.0% of the shares of the company are sold short.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a research note on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy”.

Eurofins Scient Stock Performance

Shares of Eurofins Scient stock traded down $2.29 during mid-day trading on Thursday, reaching $80.71. 3,277 shares of the stock traded hands, compared to its average volume of 9,565. The business has a 50-day moving average of $74.97 and a 200 day moving average of $74.34. Eurofins Scient has a fifty-two week low of $48.55 and a fifty-two week high of $86.20. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.